Parsec Financial Management Inc. lifted its position in Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN – Get Rating ) by 0.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,928 shares of the biopharmaceutical company's stock after buying an additional 21 shares during the period. Parsec Financial Management Inc.'s holdings in Regeneron Pharmaceuticals were worth $8,158,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors also recently modified their holdings of REGN.

https://www.dailypolitical.com/2023/06/18/regeneron-pharmaceuticals-inc-nasdaqregn-stock-position-increased-by-parsec-financial-management-inc.html

#dailypolitical